Medicare Enrolled
Dr. Joseph Abijay, MD
Clinical Neurophysiology Physician · Odessa, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Abijay from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Abijay?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Abijay
Dr. Joseph Abijay is a clinical neurophysiology physician in Odessa, TX, with 21 years of NPI registration. Based on federal Medicare data, Dr. Abijay performed 1,670 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Abijay received a total of $16,233 from 54 pharmaceutical and/or device companies across 971 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Abijay is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 28% volume in TX
$16,233 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,670
Medicare services
Top 28% in TX for clinical neurophysiology physician
Not available
Unique patients (not deduplicated)
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
800 | $82 | $137 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
195 | $59 | $95 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
140 | $115 | $171 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
130 | $31 | $42 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
119 | $98 | $149 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
98 | $113 | $193 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
51 | $61 | $86 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
33 | $75 | $112 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
28 | $166 | $269 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
26 | $96 | $153 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
23 | $60 | $80 |
| Injection of anesthetic or steroid into upper neck and back of head nerve An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head. |
14 | $57 | $114 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
13 | $127 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$16,233
Total received (2018-2024)
Avg $2,319/year across 7 years
Top 15% in TX for clinical neurophysiology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
971
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,891
2023
$2,381
2022
$2,721
2021
$3,339
2020
$1,981
2019
$1,343
2018
$1,576
Payments by company (2024)
ABBVIE INC.
$703
PFIZER INC.
$337
Lilly USA, LLC
$264
Biogen, Inc.
$166
Teva Pharmaceuticals USA, Inc.
$165
MDD US Operations, LLC
$161
Abbott Laboratories
$159
Neurocrine Biosciences, Inc.
$142
SK Life Science, Inc.
$138
Novartis Pharmaceuticals Corporation
$135
Celgene Corporation
$108
ACADIA Pharmaceuticals Inc
$80
Genentech USA, Inc.
$57
Amneal Pharmaceuticals LLC
$45
Vanda Pharmaceuticals Inc.
$42
Amgen Inc.
$40
Grifols USA, LLC
$38
ANI Pharmaceuticals, Inc.
$26
Eisai Inc.
$26
Kyowa Kirin, Inc.
$24
Neurelis, Inc.
$19
UCB, Inc.
$15
Top 3 companies account for 45.1% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,348
Biogen, Inc.
$1,064
AbbVie Inc.
$1,035
Teva Pharmaceuticals USA, Inc.
$981
Amgen Inc.
$918
PFIZER INC.
$878
Lilly USA, LLC
$853
Novartis Pharmaceuticals Corporation
$815
Abbott Laboratories
$684
Supernus Pharmaceuticals, Inc.
$679
Sunovion Pharmaceuticals Inc.
$506
Genentech USA, Inc.
$486
Neurocrine Biosciences, Inc.
$471
UCB, Inc.
$397
Biohaven Pharmaceutical Holding Company Ltd.
$396
SK Life Science, Inc.
$387
Biohaven Pharmaceuticals, Inc.
$385
Amneal Pharmaceuticals LLC
$345
Kyowa Kirin, Inc.
$338
Celgene Corporation
$302
Upsher-Smith Laboratories LLC
$292
Allergan, Inc.
$243
ACADIA Pharmaceuticals Inc
$218
Acorda Therapeutics, Inc
$201
GENZYME CORPORATION
$189
Lundbeck LLC
$187
MDD US Operations, LLC
$180
EMD Serono, Inc.
$178
Neurelis, Inc.
$129
Grifols USA, LLC
$117
E.R. Squibb & Sons, L.L.C.
$105
Horizon Therapeutics plc
$91
UPSHER-SMITH LABORATORIES LLC
$86
Otsuka America Pharmaceutical, Inc.
$86
Zyla Life Sciences
$70
ARGENX US, INC.
$66
AbbVie, Inc.
$60
Medtronic, Inc.
$44
Vanda Pharmaceuticals Inc.
$42
Takeda Pharmaceuticals U.S.A., Inc.
$39
Alexion Pharmaceuticals, Inc.
$38
US WorldMeds, LLC
$36
Impax Laboratories, Inc.
$30
Octapharma USA, Inc.
$29
ANI Pharmaceuticals, Inc.
$26
Eisai Inc.
$26
CSL Behring
$23
Vertical Pharmaceuticals, LLC
$23
ARBOR PHARMACEUTICALS, INC.
$23
PORTOLA PHARMACEUTICALS, INC.
$22
Mallinckrodt Enterprises LLC
$21
LivaNova USA, Inc.
$19
Zyla Life Sciences, Inc.
$15
Harmony Biosciences LLC
$13
Top 3 companies account for 21.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · Briviact · COMIRNATY · COPAXONE · CoreValve Evolut · DUOPA · Duopa · EMGALITY · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · Gocovri · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KYNMOBI · LEQEMBI · LYRICA · Leqembi · MAYZENT · Mavenclad · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Neuromodulation Disposables and Accessories · Neuromodulation Dspsbls and Accs · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PAXLOVID · PLEGRIDY · POMPE - DISEASE · PONVORY · PURIFIED CORTROPHIN GEL · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RELEXXII · REXULTI · REYVOW · RYTARY · Rebif · SOLIRIS · SPINRAZA · SPRIX · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · UPLIZNA · VALTOCO · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Xadago · ZEPOSIA · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Clinical neurophysiology physicians in nearby ZIP areas
1
County median income
$71,031
Nearest hospital to ZIP centroid (approximate)
MEDICAL CENTER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Abijay is a clinical cardiology specialist, with above-average Medicare volume (top 28% in TX), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Abijay experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Abijay performed 800 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Abijay receive payments from pharmaceutical companies?
Yes. Dr. Abijay received a total of $16,233 from 54 companies across 971 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Abijay's costs compare to other clinical neurophysiology physicians in Odessa?
Dr. Abijay's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Abijay) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Clinical Neurophysiology Physicians in Odessa
Browse clinical neurophysiology physicians in Odessa ranked by procedure volume and transparency data.
Highest volume
Top Clinical Neurophysiology Physicians in TX
Clinical neurophysiology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Clinical Neurophysiology Physicians in TX
Which TX clinical neurophysiology physicians receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology